Skip to content

Effect of Celery Extract Formulated Capsule on the Treatment of High Blood Pressure

Formulation of Celery Seed Extract Capsule and Clinical Evaluation of its Anti-Hypertensive Effect in a Randomized, Cross-Over, Double-Blind, Placebo-Controlled Study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130418013058N8
Enrollment
50
Registered
2018-04-22
Start date
2018-04-04
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Blood Pressure. Essential (primary) hypertension

Interventions

Intervention 1: Intervention Group: Add Celery Capsule to the Drug Therapy in Blood Pressure Patients. Intervention 2: Control Group: Placebo Capsule.

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age Between 20 and 60 Years Old (Due to the Possibility of Taking Anti-Hypertensive Drugs at the Age of 60 Years and the Probability of Severe Decrease with the Simultaneous Administration of Drugs above 60 Years of Age) Systolic Blood Pressure 120-159 mm Hg, and Diastolic Blood Pressure 80-99 mm Hg at the Beginning of the Study and in the First Visit Ability to Understand the Generalities of the Study, Interventions and Possible Complications Signing Consent Form Conscious

Exclusion criteria

Exclusion criteria: Use of Cigarettes or Nicotine Pregnancy or Breastfeeding Liver or Kidney Failure Coronary Artery Disease, Aortic Stenosis Severe Infectious and Viral and Inflammatory Diseases Associated with Fever Any Side Effects that the Patient cannot continue the Study or the Diagnosis of the Doctor does not Extend to the Patient The Occurrence of Allergic Symptoms that continue to be judged by a Doctor is not Advisable for the Patient. Patients taking the Blood Pressure Medication with the CCB Mechanism

Design outcomes

Primary

MeasureTime frame
Blood Pressure. Timepoint: Every Two Weeks. Method of measurement: Holter Device.

Secondary

MeasureTime frame
Complete Blood Test; Probably Side Effects of the Capsule. Timepoint: Every Two Weeks. Method of measurement: Blood Test; Interview.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Seyed Ahmad Mohajeri

Mashhad University of Medical Sciences

mohajeria@mums.ac.ir+98 51 3882 3251

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 13, 2026